Innate Pharma SA Class A documents

Explore the latest documents from Innate Pharma SA Class A, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Corporate Presentation

Jun 20, 2025

Slides

Q1 2025

May 13, 2025

Transcript

Slides

Earnings release6-K

Earnings release

Corporate Presentation

Apr 2, 2025

Slides

Investor Update

Feb 5, 2025

Transcript

Slides

Corporate Presentation

Feb 4, 2025

Slides

43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 14, 2025

Slides

2024

Q4 2024

Mar 27, 2025

Transcript

Annual report20-F

Earnings release

Slides

Earnings release6-K

Report

Corporate Presentation

Nov 19, 2024

Slides

Q3 2024

Nov 13, 2024

Slides

Earnings release

Status Update

Oct 3, 2024

Slides

Press release

Corporate Presentation

Sep 25, 2024

Slides

Q2 2024

Sep 12, 2024

Slides

Earnings release

Study Result

Jun 11, 2024

Slides

Press release

Q1 2024

May 14, 2024

Slides

Earnings release

2023

Q4 2023

Mar 21, 2024

Annual report20-F

Slides

Annual report

Study Result

Dec 12, 2023

Press release

Q3 2023

Nov 14, 2023

Earnings release

Slides

Q2 2023

Sep 14, 2023

Earnings release

Slides

Q1 2023

May 10, 2023

Slides

Earnings release

2022

Q4 2022

Mar 23, 2023

Annual report20-F

Slides

Annual report

Q3 2022

Nov 14, 2022

Earnings release

Slides

Q2 2022

Sep 14, 2022

Earnings release

Slides

Q1 2022

May 9, 2022

Earnings release

Slides

2021

Q4 2021

Mar 24, 2022

Annual report20-F

Annual report

Slides

Q3 2021

Nov 16, 2021

Earnings release

Slides

Q2 2021

Sep 15, 2021

Interim report

Slides

Q1 2021

May 11, 2021

Interim report

Slides